�now we know the astonishing truth that some patients are waiting a year or more just to get treatment. it�s simply not good enough.�....

treatment delays are also causing needless anxiety and distress to patients as well as putting lives at serious risk..

following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv).